Alexion Pharmaceuticals Manager, Public Affairs and Strategic Partnerships in Boston, Massachusetts
This position can be based from Boston, MA or be remote/virtual, based anywhere within the United States and may require up to 20% travel to existing Alexion sites.
The manager is part of the Corporate Affairs organization. The manager is accountable for partnering and delivery across multiple projects on time and with high quality. This position focuses on projects within the Corporate Affairs team and will provide overall project management including management of scope, schedule, risks, issues, and deliverables. The manager will also conduct landscape research and analysis, assist in managing external and internal vendors, and work with multiple Alexion stakeholders, to develop and manage integrated project schedules that drives project execution across multiple workstreams. Workstreams include reputation analysis and measurement, strategic partnerships, and team operations. The manager will also develop first drafts of needed materials, including internal memos, PowerPoint decks, and correspondence with internal and external partners.
The position works closely with the internal and external partners, serving as a relationship and project manager. This includes R and D, corporate communications, policy, and human experience teams on strategic initiatives impacting Alexion’s reputation and strategic partnerships.
The project manager will:
Drive project management processes (including scope, schedule, risk, issue, resource and budget management)
Develop and maintain integrated project plan, status reports, a deliverables
Provide input on potential measurement and partnership activities
Develop materials, support partners,
Research and analyze potential approaches and landscape opportunities
Manage and prepare project status reporting
Efficiently identify and resolve project issues; Escalate issues that require attention
Minimum 5 years of experience in healthcare, market research, or project management
Expert project management skills, with proven track record of leading broad, complex and/or strategic projects combined with the ability to execute at tactical project-level activities and tasks including defining project scope, integrated project scheduling , status reporting to all levels of stakeholders
Proven ability to do quick turnaround research and analysis
Track record of contributing to executive facing presentations
Demonstrated skill as a research analyst on external affairs issues, eg media analysis, policy analysis, message research
High-level capability for concise story-telling via PowerPoint
Drive for high quality and ability to collaborate with other stakeholders to achieve high goals
Ability to work with cross-functional stakeholders to establish and ensure a reliable and productive working relationship, including with vendor partners
Excellent written and oral communication skills
3+ years experience with pharmaceutical industry and/or healthcare topics
2+ year experience in consulting or agency environment preferred
Understanding of the pharmaceutical industry market, reputational issues, and reputational or media analysis preferred
- Bachelor’s degree
Some opportunities happen only once in a lifetime - like a job where you have the extraordinary opportunity to change lives. At Alexion, such opportunities arise through our unwavering mission to serve patients and families affected by rare diseases. These patients are our guiding star, and we act with integrity, urgency, and discipline because we know their lives are at stake.
Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D) as well as the first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases and an oral Factor D inhibitor as well as several early-stage therapies, including one for light chain (AL) amyloidosis, a second oral Factor D inhibitor and a third complement inhibitor. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, metabolic disorders and cardiology. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries. Further information about Alexion can be found at: www.alexion.com.
As a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more.